|
WO2004058755A2
(en)
*
|
2002-12-24 |
2004-07-15 |
Biofocus Plc |
Compound libraries of imidazo[1,5-a]pyridin-3-yl derivatives and related heterobicycles for targetting compounds capable of binding to g-protein coupled receptors
|
|
EP1664042A1
(en)
|
2003-09-03 |
2006-06-07 |
Galapagos N.V. |
IMIDAZO 1,5-a PYRIDINE OR IMIDAZO 1,5-a PIPERIDINE DERIVATIVES AND THEIR USE FOR THE PREPARATION OF MEDICAMENT AGAINST 5-HT2A RECEPTOR-RELATED DISORDERS
|
|
WO2008022060A2
(en)
|
2006-08-14 |
2008-02-21 |
Novartis Ag |
Imidazo-pyridine derivatives for modulating protein kinase activity
|
|
EP2526934B1
(en)
*
|
2006-09-22 |
2015-12-09 |
Pharmacyclics LLC |
Inhibitors of bruton's tyrosine kinase
|
|
SG10202107066WA
(en)
|
2007-03-28 |
2021-07-29 |
Pharmacyclics Llc |
Inhibitors of bruton's tyrosine kinase
|
|
EP2283020B8
(en)
|
2008-05-19 |
2012-12-12 |
OSI Pharmaceuticals, LLC |
Substituted imidazopyr-and imidazotri-azines
|
|
CN102918042B
(zh)
|
2010-02-08 |
2016-03-09 |
默沙东有限责任公司 |
8-甲基-1-苯基-咪唑[1,5-a]吡嗪化合物
|
|
US20140221354A1
(en)
|
2011-03-31 |
2014-08-07 |
Emblem Technology Transfer Gmbh |
IMIDAZO [1,2-a]PYRIDINE COMPOUNDS FOR USE IN THERAPY
|
|
GB2486038B
(en)
*
|
2011-06-28 |
2013-09-25 |
Andrew Levine |
Speech-to-text conversion
|
|
EP2548877A1
(en)
|
2011-07-19 |
2013-01-23 |
MSD Oss B.V. |
4-(5-Membered fused pyridinyl)benzamides as BTK-inhibitors
|
|
EP3495368B1
(en)
|
2011-07-19 |
2023-05-31 |
Merck Sharp & Dohme B.V. |
(s)-4-(8-amino-3-(1-(but-2-ynoyl)pyrrolidin-2-yl)imidazo[1,5-a]pyrazin-1-yl)-2-methoxy-n-(pyridin-2-yl)benzamide as btk-inhibitor
|
|
EP2734523A1
(en)
|
2011-07-19 |
2014-05-28 |
Merck Sharp & Dohme B.V. |
4-imidazopyridazin-1-yl-benzamides and 4-imidazotriazin-1-yl-benzamides btk-inhibitors
|
|
FR2985185B1
(fr)
*
|
2012-01-04 |
2013-12-27 |
Sanofi Sa |
Utilisation en therapeutique de derives d'imidazopyridine
|
|
US9458162B2
(en)
*
|
2012-01-31 |
2016-10-04 |
Nanjing Allgen Pharma Co. Ltd. |
Cyclic molecules as bruton's tyrosine kinase inhibitors
|
|
US9481682B2
(en)
|
2013-01-23 |
2016-11-01 |
Merck Sharp & Dohme Corp. |
Substituted benzamides and substituted pyridinecarboxamides as Btk inhibitors
|
|
WO2014113942A1
(en)
|
2013-01-23 |
2014-07-31 |
Merck Sharp & Dohme Corp. |
Btk inhibitors
|
|
RU2016110016A
(ru)
*
|
2013-08-22 |
2017-09-27 |
Ф. Хоффманн-Ля Рош Аг |
Алкиниловые спирты и способы их применения
|
|
WO2015057992A1
(en)
|
2013-10-16 |
2015-04-23 |
Izumi Raquel |
Btk inhibitors for hematopoietic mobilization
|
|
WO2015157955A1
(en)
|
2014-04-17 |
2015-10-22 |
Abbvie Inc. |
Heterocyclic btk inhibit ors
|
|
CN105017256A
(zh)
*
|
2014-04-29 |
2015-11-04 |
浙江导明医药科技有限公司 |
多氟化合物作为布鲁顿酪氨酸激酶抑制剂
|
|
WO2016106652A1
(en)
|
2014-12-31 |
2016-07-07 |
Merck Sharp & Dohme Corp. |
Biarylether imidazopyrazine btk inhibitors
|
|
WO2016106623A1
(en)
*
|
2014-12-31 |
2016-07-07 |
Merck Sharp & Dohme Corp. |
Benzamide imidazopyrazine btk inhibitors
|
|
WO2016106626A1
(en)
|
2014-12-31 |
2016-07-07 |
Merck Sharp & Dohme Corp. |
Imidazopyrazine analogs with 3-tertiary carbon substitutions as btk inhibitors
|
|
MA41614A
(fr)
*
|
2015-02-25 |
2018-01-02 |
Alios Biopharma Inc |
Composés antiviraux
|
|
MA42242A
(fr)
*
|
2015-06-24 |
2018-05-02 |
Principia Biopharma Inc |
Inhibiteurs de la tyrosine kinase
|
|
WO2017033113A1
(en)
*
|
2015-08-21 |
2017-03-02 |
Acerta Pharma B.V. |
Therapeutic combinations of a mek inhibitor and a btk inhibitor
|
|
CN106478633A
(zh)
*
|
2015-08-27 |
2017-03-08 |
正大天晴药业集团股份有限公司 |
一类布鲁顿酪氨酸激酶抑制剂
|
|
US20170071962A1
(en)
*
|
2015-09-11 |
2017-03-16 |
Acerta Pharma B.V. |
Therapeutic Combinations of a Proteasome Inhibitor and a BTK Inhibitor
|
|
US20170035881A1
(en)
*
|
2015-10-19 |
2017-02-09 |
Acerta Pharma B.V. |
Therapeutic Combinations of an IRAK4 Inhibitor and a BTK Inhibitor
|
|
WO2017077507A1
(en)
*
|
2015-11-06 |
2017-05-11 |
Acerta Pharma B.V. |
Imidazopyrazine inhibitors of bruton's tyrosine kinase
|
|
CA3017567A1
(en)
|
2016-03-11 |
2017-09-14 |
Corvus Pharmaceuticals, Inc. |
Compounds and methods for modulating bruton's tyrosine kinase
|
|
KR102215172B1
(ko)
|
2016-06-30 |
2021-02-16 |
항저우 방순 파마슈티컬 컴퍼니, 리미티드 |
이미다조피라진아민 페닐 유도체 및 그의 용도
|
|
EP3492471B1
(en)
|
2016-08-17 |
2020-12-02 |
Shenzhen TargetRx, Inc. |
Fused bicyclic compound for inhibiting activity of tyrosine kinase
|
|
WO2018175512A1
(en)
*
|
2017-03-22 |
2018-09-27 |
Suzhou Baijibugong Pharmaceutical Technology Co. Ltd. |
Bruton's tyrosine kinase inhibitors
|